Perioperative Management of Clopidogrel for Orbital Floor Reconstruction

Rationale for Discontinuation Timing

Clopidogrel should be discontinued 5-7 days before orbital floor reconstruction surgery to minimize bleeding risk while allowing adequate time for platelet function recovery, as recommended by the American Society of Anesthesiologists 1, 2
Clopidogrel causes irreversible inhibition of platelets for their entire lifespan (7-10 days), requiring 5-7 days for adequate recovery of platelet function before surgery, according to the American Heart Association 1, 2

For patients with recent coronary stent placement or acute coronary syndrome, the American College of Chest Physicians recommends delaying elective orbital floor reconstruction for at least 4-6 weeks after bare metal stent placement and at least 6 months after drug-eluting stent placement 3, 4, 5
For high thrombotic risk patients, consultation with cardiology before discontinuing clopidogrel is recommended by the American Heart Association 6

Unlike aspirin, which can be continued for many procedures, clopidogrel should be discontinued before orbital surgery due to the confined surgical space and risk of vision-threatening hemorrhage, as stated by the American Society of Anesthesiologists 1, 2
Consider use of tranexamic acid to reduce bleeding risk during surgery, as recommended by the American Society of Anesthesiologists 1, 2

The decision to discontinue clopidogrel must balance bleeding risk against thrombotic risk, according to the American College of Chest Physicians 3
Aspirin monotherapy (if patient is on dual antiplatelet therapy) should also be discontinued 5 days before orbital surgery, unlike many other procedures where aspirin can be continued, as recommended by the American Society of Anesthesiologists 2